BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marcus JL, Hurley LB, Chamberland S, Champsi JH, Korn DG, Lai JB, Lam JO, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ. Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017. Open Forum Infect Dis 2020;7:ofaa044. [PMID: 32128339 DOI: 10.1093/ofid/ofaa044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Jo HH, Min C, Kyoung DS, Park MA, Kim SG, Kim YS, Chang Y, Jeong SW, Jang JY, Lee SH, Kim HS, Jun BG, Kim YD, Cheon GJ, Yoo JJ. Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study. PLoS One 2021;16:e0253165. [PMID: 34125860 DOI: 10.1371/journal.pone.0253165] [Reference Citation Analysis]
2 Peyvandi F, Mahlangu JN, Pipe SW, Hay CRM, Pierce GF, Kuebler P, Kruse-Jarres R, Shima M. Application of a hemophilia mortality framework to the Emicizumab Global Safety Database. J Thromb Haemost 2021;19 Suppl 1:32-41. [PMID: 33331041 DOI: 10.1111/jth.15187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Pipe SW, Kruse-Jarres R, Mahlangu JN, Pierce GF, Peyvandi F, Kuebler P, De Ford C, Sanabria F, Ko RH, Chang T, Hay CRM. Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database. J Thromb Haemost 2021;19 Suppl 1:21-31. [PMID: 33331042 DOI: 10.1111/jth.15186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]